What ≥99% Purity Actually Means in Peptide Research

Open any peptide vendor’s product page in 2026 and you will see the same number printed next to every compound: ≥99% purity. The phrase has become so universal that it has stopped meaning much. Some vendors back it with a third-party Certificate of Analysis; others print it because their competitors do. The number itself is real chemistry, but the marketing version of it — a single percentage on a static product page — tells a researcher almost nothing about the lot they are about to use.

This article is the field guide we wish existed when we started buying research peptides. It walks through what HPLC purity actually measures, what it does not, why a single number is an inadequate quality signal, and the seven things a researcher should look for before trusting any “≥99%” claim.

Why purity matters in research

Reproducibility is the entire point of using research peptides instead of bulk reagents. A lot at 98.2% and a lot at 99.4% will produce systematically different dose-response data in an in-vitro assay, even when the headline label on the vial is the same. When a study fails to replicate, the cause is sometimes traced not to biology but to the variable starting material^[1].

For a researcher running comparative work across batches, a purity drift of one to two percentage points changes the actual delivered concentration of the target compound. The impurities themselves can also be biologically active, particularly when they are deletion sequences or oxidation products of the parent peptide. Knowing the headline number is not enough; knowing what is in the remaining one percent is what makes results interpretable.

What “purity” actually measures

In nearly every research-peptide COA you will encounter, purity refers to the result of reverse-phase high-performance liquid chromatography (RP-HPLC): the target peptide’s peak area divided by the total area of all peaks detected at a stated UV wavelength^[2]. A 99.0% RP-HPLC purity reading means that 99.0% of the UV-absorbing material that came off the column at that wavelength corresponds to a single peak whose retention time matches the target compound.

The technique has well-defined blind spots:

• Water contentis invisible to UV detectors. Lyophilized peptides routinely contain 3–8% residual moisture by mass; this is not part of the “purity” number.
• Counter-ions and salts— trifluoroacetate (TFA) from synthesis, acetate, hydrochloride — do not absorb at typical detection wavelengths and are excluded from the purity figure.
• Residual solvents like DMF, NMP, or DCM may be present below the detection threshold of the method and are screened separately by GC, not HPLC.
• Endotoxin and microbial contamination are screened by orthogonal assays (LAL, TAMC/TYMC) and are not represented anywhere in an HPLC purity number.

None of this makes HPLC purity unreliable — it is the most informative single measurement available for a research peptide. It does mean the headline number is one chapter of a longer document, not a verdict.

How HPLC purity is measured

A reverse-phase analysis dissolves the lyophilized peptide in a known solvent, injects a precise volume onto a non-polar stationary phase, and elutes it with a gradient of increasingly organic mobile phase — typically water and acetonitrile, both modified with TFA to protonate basic residues^[3]. As compounds elute they pass through a UV detector tuned to a specific wavelength, usually 210 or 220 nm to capture the peptide bond’s absorbance.

The integrated chromatogram — the trace of detector signal over time — is what produces the purity number. Software identifies the peak corresponding to the target peptide (typically the largest peak), then sums its area and divides by the total area of all peaks in the chromatogram (Figure 1).

The minimum elements a researcher should be able to find in the method description:

A COA that prints a percentage but omits any of the above is not transparent enough to be actionable. A researcher trying to reproduce or compare results across lots needs to know the method, not just the conclusion.

“Tested” vs. third-party tested

The single most consequential distinction in a peptide vendor’s quality posture is whether testing is performed in-house or by an independent, accredited laboratory. Both can be technically valid; their failure modes are different.

In-house testing is fast, easy to misuse, and structurally vulnerable to selection bias. A vendor running its own HPLC has every incentive to keep retesting until the result is favorable, or to choose a method with low resolving power that produces flattering numbers. Third-party testing by an ISO 17025-accredited lab introduces audit trails, method validation requirements, and a financial structure that does not reward generous results. It is not infallible — the wrong method run at an accredited lab still produces a poor result — but it is the floor below which credibility collapses.

Why a single number is insufficient

Even a properly produced 99.4% HPLC purity figure has a shelf life. Three structural issues prevent it from serving as a permanent quality claim:

Storage degradation

Peptides are not inert. Methionine residues oxidize, asparagine and glutamine residues deamidate, disulfide bonds rearrange, and aspartic acid residues isomerize — all on timescales relevant to retail storage^[4]. A vial tested at 99.4% purity in January can read 97.8% by December if storage conditions allowed slow degradation. The printed number on a product page is the day-of-test value, not the day-of-shipment value.

Batch-to-batch variation

Solid-phase peptide synthesis is a chemical process with finite yield at each coupling step. A 30-residue peptide synthesized at 99.5% step-wise efficiency yields a parent compound at roughly 86% of the crude product, with the rest being deletion sequences and side products that purification then removes. Different batches reach the final purity threshold via different impurity profiles. Lot 8K-2410 and lot 8K-2503 may both certify at ≥99% — but the impurity composition behind that number can differ.

Time since test

A COA dated eighteen months before the vial ships is meaningfully different from one dated last quarter. The longer the gap, the larger the room for storage-induced drift, and the more important re-test data becomes for the buyer’s confidence interval.

What a complete COA should contain

A Certificate of Analysis worth the name documents enough to allow a third party to evaluate the result, not just announce it. The minimum:

• Lot identifier. Unique to this batch. The COA in your hand should match the lot printed on the vial.
• Test date and analyst.When the analysis was performed and by whom (the accredited lab’s name, not the vendor’s).
• HPLC method. Column, gradient, wavelength, injection volume, runtime. A chromatogram image is the gold-standard disclosure.
• Identity confirmation. Mass spectrometry showing the observed mass within tolerance of the theoretical monoisotopic mass for the target sequence.
• Contaminant screening. Endotoxin (LAL), residual solvents (GC), microbial bioburden where relevant.
• Water content / counter-ion content. Karl Fischer titration for water; ion chromatography for TFA or acetate.
• Retest history. If the lot has been re-analyzed during storage, the dates and results of those analyses.

A COA missing several of these does not necessarily indicate a bad product. It indicates an opaque one. For research work, opacity is itself a defect.

Reading the PepMax COA

Every order shipped by PepMax includes a lot-specific COA covering each item in the accompanying field set. The COA is also available on the corresponding product page before purchase, indexed by lot. Each document contains the seven elements above; each lot is archived in our public COA library so that a researcher can audit our claims at any time without contacting support.

A 7-point evaluation checklist

Before relying on a vendor’s purity claim — ours, theirs, anyone’s — check that you can answer yes to all seven of these questions for the specific lot you are about to use:

1. Is the COA lot-specific, with the lot number matching the vial label?
2. Is it produced by a third-party, accredited laboratory (ISO 17025 or equivalent)?
3. Does it state the HPLC method — column, gradient, wavelength — not just a percentage?
4. Does it include mass spectrometry identity confirmation?
5. Does it screen for residual solvents and endotoxin at minimum?
6. Is the test date recent enough to be informative for the storage interval since synthesis?
7. Is the COA auditable — published or available on request, not paraphrased into a summary table?

If a vendor cannot produce a yes for all seven, the “≥99% purity” claim on their product page is marketing language, not a measurement you can use.